TET2 mutations frequently occur in AML, myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), whereas TET1 and TET3 mutations rarely happen [11, 12]. This evidence concerns the gene TET2 and myelodysplastic syndrome.